Shinji Kageyama

Title: The Innovations of Shinji Kageyama

Introduction

Shinji Kageyama is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-asthmatic agents. His work has led to advancements that enhance the effectiveness of treatments for asthma patients.

Latest Patents

Kageyama holds a patent for an anti-asthmatic composition and the process for preparing it. The patent, titled "5-(3-n-Butyloxalylaminophenyl) tetrazole," demonstrates an excellent SRS-A release-inhibiting effect. This compound serves as an effective component for an anti-asthmatic agent. The pharmaceutical preparation, which combines the tetrazole with a specific dispersant such as polysorbate-80 in the presence of a non-aqueous solvent, exhibits high solubility and bioavailability.

Career Highlights

Shinji Kageyama is associated with Wakamoto Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new treatments that improve the quality of life for individuals suffering from asthma.

Collaborations

Kageyama has collaborated with notable colleagues, including Takao Shida and Yoshiaki Ogasawara. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Shinji Kageyama's contributions to the field of pharmaceuticals, particularly in anti-asthmatic treatments, highlight his role as a significant inventor. His innovative work continues to impact the lives of many individuals suffering from respiratory conditions.